EFFECTS OF TYPE-I AND TYPE-II INTERFERONS ON 90K ANTIGEN EXPRESSION IN OVARIAN-CARCINOMA CELLS

被引:28
作者
MARTH, C
DREPS, A
NATOLI, C
ZEIMET, AG
LANG, T
WIDSCHWENDTER, M
DAXENBICHLER, G
ULLRICH, A
IACOBELLI, S
机构
[1] UNIV INNSBRUCK HOSP,DEPT OBSTET & GYNECOL,A-6020 INNSBRUCK,AUSTRIA
[2] MAX PLANCK INST BIOCHEM,MARTINSRIED,GERMANY
[3] UNIV G DANNUNZIO,CHAIR MED ONCOL,CHIETI,ITALY
关键词
D O I
10.1002/ijc.2910590617
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Antigen 90K is produced by several tumor-cell lines and by patients with cancer. Its function has not yet been clarified, although recent reports suggest that it plays a role in the tumor-host relationship-for example by stimulation of natural killer and lymphokine-activated killer-cell activity. Previous studies have indicated that 90K expression may be under the influence of interferon-alpha. Here, we provide evidence that both interferon-alpha and -gamma can enhance the secretion of 90K and augment the level of specific mRNA expression in 3 ovarian carcinoma cell lines (OVCAR-3, HTB-77 and SKOV-6). However, interferon-gamma leads to depletion of cellular 90K whereas interferon-alpha increases both secreted and cellular 90K levels. In equimolar concentrations, Interferon-alpha was always superior to interferon-gamma in augmenting 90K protein or mRNA levels. Combinations of TNF with interferon-gamma were highly synergistic both in reducing cell proliferation and in increasing 90K secretion and mRNA expression. This synergism was seen to a lesser extent with interferon-alpha. (C) 1994 Wiley-Liss, Inc.
引用
收藏
页码:808 / 813
页数:6
相关论文
共 24 条
[1]   A 90-KDA PROTEIN SERUM MARKER FOR THE PREDICTION OF PROGRESSION TO AIDS IN A COHORT OF HIV-1+ HOMOSEXUAL MEN [J].
BRIGGS, NC ;
NATOLI, C ;
TINARI, N ;
DEGIDIO, M ;
GOEDERT, JJ ;
IACOBELLI, S .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (09) :811-816
[2]  
CHICHEPORTICHE Y, 1994, J BIOL CHEM, V269, P5512
[3]  
FLEUREN GJ, 1987, VIRCHOWS ARCH A, V410, P481
[4]   AN ANCIENT, HIGHLY CONSERVED FAMILY OF CYSTEINE-RICH PROTEIN DOMAINS REVEALED BY CLONING TYPE-I AND TYPE-II MURINE MACROPHAGE SCAVENGER RECEPTORS [J].
FREEMAN, M ;
ASHKENAS, J ;
REES, DJG ;
KINGSLEY, DM ;
COPELAND, NG ;
JENKINS, NA ;
KRIEGER, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (22) :8810-8814
[5]   CLONING AND CHARACTERIZATION OF CYCLOPHILIN C-ASSOCIATED PROTEIN - A CANDIDATE NATURAL CELLULAR LIGAND FOR CYCLOPHILIN-C [J].
FRIEDMAN, J ;
TRAHEY, M ;
WEISSMAN, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (14) :6815-6819
[6]  
GASTL G, 1985, CANCER RES, V45, P2957
[7]   RECOMBINANT INTERFERON ENHANCES MONOCLONAL-ANTIBODY - TARGETING OF CARCINOMA LESIONS INVIVO [J].
GREINER, JW ;
GUADAGNI, F ;
NOGUCHI, P ;
PESTKA, S ;
COLCHER, D ;
FISHER, PB ;
SCHLOM, J .
SCIENCE, 1987, 235 (4791) :895-898
[8]   ENHANCED EXPRESSION OF BETA-2-MICROGLOBULIN AND HLA ANTIGENS ON HUMAN LYMPHOID-CELLS BY INTERFERON [J].
HERON, I ;
HOKLAND, M ;
BERG, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1978, 75 (12) :6215-6219
[9]  
IACOBELLI S, 1986, CANCER RES, V46, P3005
[10]   PURIFICATION AND CHARACTERIZATION OF A 90-KDA PROTEIN RELEASED FROM HUMAN TUMORS AND TUMOR-CELL LINES [J].
IACOBELLI, S ;
BUCCI, I ;
DEGIDIO, M ;
GIULIANI, C ;
NATOLI, C ;
TINARI, N ;
RUBISTEIN, M ;
SCHLESSINGER, J .
FEBS LETTERS, 1993, 319 (1-2) :59-65